Which immunotherapy companies will be around in 2028?
Mini
8
Ṁ1592028
1D
1W
1M
ALL
62%
Wyndly
60%
Curex
59%
Nectar
I'm trying to pick a provider for at-home sublingual immunotherapy (SLIT), but it takes up to four years to finish and I'm worrying about a startup going out of business or being acquired and no longer offering immunotherapy.
Curex:
founded 2020
can't find funding info
Wyndly:
founded 2020
2mil funding in 2023
yc W21 company
Nectar:
founded 2021
24mil total raised, series a
Get Ṁ1,000 play money
Related questions
Related questions
If I get immunotherapy from a startup, will it turn out to be a good idea?
Can we cure at least one autoimmune disease in humans by 2028?
45% chance
Will Immunovant agree to be acquired by the end of 2024?
23% chance
Which biotech scaleup will have the largest market cap in 2030?
Of the companies which are currently #11-20 in market cap, will any be larger than Eli Lilly (#10) at the end of 2024?
64% chance
Will a publicly listed pharma company reach $1T in market cap before 2025?
51% chance
Will FDA approve any mRNA vaccine against melanoma before 2028?
49% chance
Will a cancer therapy approved by the FDA before 2027 successfully cure >1 cancer type?
63% chance
Will we get a cure for cancer before 2038?
35% chance
By 2030, will the FDA approve any drug in combination with a checkpoint blockade therapy that substantially reduces immune escape?
54% chance